News

The funding is expected to help smaller centres conduct high-quality research and achieve critical mass in priority areas, including respiratory and gastrointestinal diseases. The biomedical research units were

The products covered by the agreement include GSK’s entire dermatology portfolio, certain anti-infective products and smoking cessation aid Zyban. The dermatology portfolio includes Betnovat, one of the Swedish

The data evaluated BSI-201 as both a single agent and in combination with topotecan in human OVCAR-3 xenografts resistant to adriamycin, melphalan and cisplatin. Administered as monotherapy, BSI-201

Under the terms of the agreement, Roche acquired 100% of Piramed’s shares for $160 million, plus a milestone payment of $15 million, which is due upon the commencement

Under the strategic alliance, the companies expect to launch the product in the fourth quarter of 2010. IntelGenx will complete the development of the product, using its patented

Researchers conducted studies with PCI-32765 examining the downstream signaling events in the B-cell receptor (BCR) signal transduction pathways. In vitro drug treatment of B-cell lymphomas blocked BCR mediated

The two companies will collaborate on sponsor-initiated clinical trials and will offer each other their country-specific skills and insights. Rebecca Li, vice president of clinical research at New

Hydresia G2, a natural emulsion base, retains all of the functional performance properties of Botaneco’s first generation Hydresia product, while offering formulators the ability to develop products over

The company’s planned multi-center, double-blind, placebo-controlled study would enroll up to 300 patients. 200 patients will be allowed for enrollment through a recently approved $1.9 million grant from